DR. ANGELIKI GEORGOPOULOS, M.D.
Osteopathic Medicine at Veterans Dr, Minneapolis, MN

License number
Minnesota D0023972
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
1 Veterans Dr, Minneapolis, MN 55417
Phone
(612) 467-5537
(612) 727-5630 (Fax)

Professional information

Angeliki Georgopoulos Photo 1

Dr. Angeliki Georgopoulos, Baltimore MD - MD (Doctor of Medicine)

Specialties:
Endocrinology, Diabetes & Metabolism, Diabetes Medicine
Address:
3415 Guilford Ter, Baltimore 21218
Minneapolis VA Health Care System
1 Veterans Dr, Minneapolis 55417
(612) 725-2000 (Phone)
1 Veterans Dr, Minneapolis 55417
(612) 467-5537 (Phone), (612) 727-5630 (Fax)
Languages:
English
Education:
Medical School
Faculty Of Medsch Of Health Science Nat`Lkapodistrian University Of Athens
Johns Hopkins Hospital


Angeliki A Georgopoulos Photo 2

Angeliki A Georgopoulos, Minneapolis MN

Specialties:
Pediatric Emergency Medicine, Endocrinology, Diabetes & Metabolism, Geriatric Medicine
Work:
One Veterans Drive
1 Veterans Dr, Minneapolis, MN 55417
Education:
University Of Athens (1966)


Angeliki Georgopoulos Photo 3

Angeliki Georgopoulos, Minneapolis MN

Specialties:
Endocrinologist
Address:
1 Veterans Dr, Minneapolis, MN 55417


Angeliki Georgopoulos Photo 4

Method Of Administering Insulin

US Patent:
5320094, Jun 14, 1994
Filed:
Jan 10, 1992
Appl. No.:
7/819234
Inventors:
Beth L. Laube - Baltimore MD
G. Kenneth Adams - Bloomfield NJ
Angeliki Georgopoulos - Minneapolis MN
Assignee:
The Johns Hopkins University - Baltimore MD
International Classification:
A61M 1500, A61M 1610, A61M 1100, A62B 700
US Classification:
12820312
Abstract:
A method of delivering a protein, in particular insulin, to the lungs. The method is characterized in that an aerosolized mist of small particles is produced in an associated medicament delivery chamber, the distance from the chamber to the patient's mouth is set to slow the speed of aerosol particles entering the mouth and the flow rate through the chamber is regulated to a low rate of less than about 30 liters per minute. It has been found that administering insulin in accordance with the invention may advantageously produce a penetration of medication into the lungs of about 90%.